SREBF1 and osteosarcoma: The bHLH-ZIP transcription factor SREBP1, the target responsible for statins’ cholesterol lowering effects, induced p21 in osteosarcoma and HepG2 cells [42], prompting us to investigate whether statins utilized SREBP1 to induce p21 in PDA cells.